Quick Takeaways
- Aravive, Inc. has 14 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider Transactions Reported by 14 Insiders of Aravive, Inc.
- Location
- Houston, TX
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 30 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Aravive, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Fredric N. Eshelman | Executive Chairman, Director, 10%+ Owner | $23,473,906 | Mixed | 24 Oct 2022 | ||
| Eric Zhang | Director | $2,581,796 | Mixed | 24 Oct 2022 | ||
| Amato Giaccia | Director | $1,116,435 | Mixed | 24 Oct 2022 | ||
| Peter Tai-Ching Ho | Director | $101,838 | Mixed | 24 Oct 2022 | ||
| Maria Carolina Petrini | Chief Commercial Officer | Mixed | 10 Apr 2023 | |||
| Sigurd C. Kirk | Director | Mixed | 23 Sep 2022 | |||
| Gail Frances McIntyre | CEO and President, Director | Mixed | 01 Feb 2023 | |||
| Vinay Shah | Chief Financial Officer | Mixed | 24 Jan 2022 | |||
| Leonard Scott Dove | Chief Operating Officer | Mixed | 01 Feb 2023 | |||
| John Hohneker | Director | Mixed | 23 Sep 2022 | |||
| Robert B. Geller | Chief Medical Officer | Mixed | 01 Feb 2023 | |||
| Rudy Howard | Chief Financial Officer | Mixed | 01 Feb 2023 | |||
| Michael W. Rogers | Director | Mixed | 23 Sep 2022 | |||
| Reshma Rangwala | Chief Medical Officer | Mixed | 24 Jan 2022 |
Top shareholders of Aravive, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Fredric N. Eshelman |
3/4/5
|
Executive Chairman, Director, 10%+ Owner |
—
mixed-class rows
|
41,824,009
mixed-class rows
|
$23,473,906 | — | 24 Oct 2022 | |
| Eric Zhang |
3/4/5
|
Director |
—
mixed-class rows
|
3,893,680
mixed-class rows
|
$2,581,796 | — | 24 Oct 2022 | |
| Amato Giaccia |
3/4/5
|
Director |
—
mixed-class rows
|
1,485,416
mixed-class rows
|
$1,116,435 | — | 24 Oct 2022 | |
| Peter Tai-Ching Ho |
3/4/5
|
Director |
—
mixed-class rows
|
219,412
mixed-class rows
|
$101,838 | — | 24 Oct 2022 | |
| Gail Frances McIntyre |
3/4/5
|
CEO and President, Director |
—
class O/S missing
|
700,000
|
— | — | 01 Feb 2023 | |
| Leonard Scott Dove |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
400,000
|
— | — | 01 Feb 2023 | |
| Maria Carolina Petrini |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
400,000
|
— | — | 10 Apr 2023 | |
| Robert B. Geller |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
400,000
|
— | — | 01 Feb 2023 | |
| Rudy Howard |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
400,000
|
— | — | 01 Feb 2023 | |
| Reshma Rangwala |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
175,000
|
— | — | 24 Jan 2022 | |
| Vinay Shah |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
175,000
|
— | — | 24 Jan 2022 | |
| John Hohneker |
3/4/5
|
Director |
—
class O/S missing
|
97,063
|
— | — | 23 Sep 2022 | |
| Michael W. Rogers |
3/4/5
|
Director |
—
class O/S missing
|
97,063
|
— | — | 23 Sep 2022 | |
| Sigurd C. Kirk |
3/4/5
|
Director |
—
class O/S missing
|
97,063
|
— | — | 23 Sep 2022 |
Recent Insider Transactions by Companies or Individuals for Aravive, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.